Literature DB >> 8444084

Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy.

E Zuccato1, M Venturi, G Di Leo, L Colombo, C Bertolo, S B Doldi, E Mussini.   

Abstract

Since the metabolic activity of the colonic flora plays a definite role in colon cancer and an increased incidence of this disease is reported after cholecystectomy, we studied the metabolic activity of the colonic flora in a group of postcholecystectomy patients and matched controls by measuring, as representative end products of the bacterial metabolism, their fecal bile acids (BA), fecal 3-methylindole (SK) and indole (IN), and respiratory methane and hydrogen. Patients had significantly higher SK and lower IN, and, among BA, higher lithocholic (LCA) and chenodeoxycholic acid concentrations and LCA/deoxycholic acid ratio in the stools than controls. Similar differences from controls were reported for colon cancer. Comparable bacterial metabolic activities are thus operative in the large bowel of postcholecystectomized and colon cancer patients. This supports the biological plausibility of the association of cholecystectomy and colon cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444084     DOI: 10.1007/bf01316508

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  56 in total

Review 1.  Cholecystectomy and colorectal cancer.

Authors:  R J Moorehead; S T McKelvey
Journal:  Br J Surg       Date:  1989-03       Impact factor: 6.939

2.  Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and steroids in man.

Authors:  B S Reddy; J H Weisburger; E L Wynder
Journal:  J Nutr       Date:  1975-07       Impact factor: 4.798

3.  Bile acids: co-mutagenic activity in the Salmonella-mammalian-microsome mutagenicity test: brief communication.

Authors:  S J Silverman; A W Andrews
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

Review 4.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

5.  Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer.

Authors:  B S Reddy; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1973-06       Impact factor: 13.506

6.  Effect of lithocholic acid on DL-ethionine carcinogenesis in rat liver.

Authors:  Y Hiasa; Y Konishi; Y Kamamoto; T Watanabe; N Ito
Journal:  Gan       Date:  1971-08

7.  Requirements for induction of DNA strand breaks by lithocholic acid.

Authors:  M S Kulkarni; B A Cox; K L Yielding
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

8.  Studies on breath methane: the effect of ethnic origins and lactulose.

Authors:  P Pitt; K M de Bruijn; M F Beeching; E Goldberg; L M Blendis
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

9.  Oxidation of hydrogen and reduction of methanol to methane is the sole energy source for a methanogen isolated from human feces.

Authors:  T L Miller; M J Wolin
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

10.  Large bowel cancer risk in cholelithiasis and after cholecystectomy. Postmortem study.

Authors:  N F Breuer; B Katschinski; E Mörtl; L D Leder; H Goebell
Journal:  Digestion       Date:  1988       Impact factor: 3.216

View more
  38 in total

Review 1.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

Review 2.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

3.  Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities.

Authors:  Un-Ho Jin; Syng-Ook Lee; Gautham Sridharan; Kyongbum Lee; Laurie A Davidson; Arul Jayaraman; Robert S Chapkin; Robert Alaniz; Stephen Safe
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

4.  Feasibility of liver graft procurement with donor gallbladder preservation in living donor liver transplantation.

Authors:  Jia-Hong Dong; Sheng Ye; Wei-Dong Duan; Wen-Bing Ji; Yu-Rong Liang
Journal:  Hepatol Int       Date:  2015-05-15       Impact factor: 6.047

Review 5.  Microbiota metabolite regulation of host immune homeostasis: a mechanistic missing link.

Authors:  S Steinmeyer; K Lee; A Jayaraman; R C Alaniz
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 6.  Are there acyl-homoserine lactones within mammalian intestines?

Authors:  Matthew C Swearingen; Anice Sabag-Daigle; Brian M M Ahmer
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

7.  Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole.

Authors:  Shelby Steinmeyer; Daniel P Howsmon; Robert C Alaniz; Juergen Hahn; Arul Jayaraman
Journal:  Biotechnol Bioeng       Date:  2017-07-27       Impact factor: 4.530

8.  Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection.

Authors:  Cynthia L Chappell; Charles Darkoh; Lawrence Shimmin; Naveed Farhana; Do-Kyun Kim; Pablo C Okhuysen; James Hixson
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

9.  A rapid and specific method for the detection of indole in complex biological samples.

Authors:  Charles Darkoh; Cynthia Chappell; Christopher Gonzales; Pablo Okhuysen
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

10.  The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation.

Authors:  Tarun Bansal; Robert C Alaniz; Thomas K Wood; Arul Jayaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.